Comparative assessment of renal complications in children during the COVID-19 pandemic

Ismoilova Ziyoda Aktamovna 1, Kilicheva Tuxtagul Abdullayevna 1 and Muhammad Arsalan Ali Sajid 2, *

1 Peadiatrics, Departmrnt of Peadiatrics at Urgench Branch of Tashkent Medical Academy, Urgench, Uzbekistan.
2 MD at Urgench Branch of Tashkent Medical Academy, Urgench, Uzbekistan., Pharmacist at University of Sargodha, Sargodha, Pakistan.
 
Research Article
World Journal of Advanced Research and Reviews, 2022, 13(02), 117–120
Article DOI: 10.30574/wjarr.2022.13.2.0032
 
Publication history: 
Received on 21 December 2021; revised on 06 February 2022; accepted on 08 February 2022
 
Abstract: 
Although medically children are not at risk, but in the ongoing COVID 19 pandemic has serious implications for children. New evidence do not clearly define renal manifestations. Among the reasons for the lack of efficacy of the ongoing treatment of patients with renal complications, an incomplete understanding of its pathogenesis in children who have had a coronavirus infection plays a special role. Biochemical blood tests revealed the elevated blood and urine MC levels which in 1/5 of the patients with high parameters. Moderate proteinuria and transient macrohaematuria were observed in children in the COVID-19 group with renal complications. Children with moderate to severe ChKD with COVID-19 or with recurrent nephrotic syndrome are at risk of severe complications, including severe AKF or ChKF. This data indicates that the children with COVID-19 infection should be closely monitored for the development and progression of RF and special measures should be taken to prevent it.
 
Keywords: 
Macrohematuria; Proteinuria; Complications; Extrapulmonary manifestations
 
Full text article in PDF: 
Share this